• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科伊酰胺 A 通过抑制自噬杀死癌细胞。

Coibamide A kills cancer cells through inhibiting autophagy.

机构信息

School of Life and Pharmaceutical Sciences, Hainan University, Haikou, 570228, China; Hainan Key Laboratory for Sustainable Utilization of Tropical Bioresources, College of Tropical Crops, Hainan University, Haikou, 570228, China; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.

Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China; Institute of Molecular Rhythm and Metabolism, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.

出版信息

Biochem Biophys Res Commun. 2021 Apr 2;547:52-58. doi: 10.1016/j.bbrc.2021.01.112. Epub 2021 Feb 13.

DOI:10.1016/j.bbrc.2021.01.112
PMID:33592379
Abstract

Natural products are useful tools for biological mechanism research and drug discovery. Due to the excellent tumor cell growth inhibitory profile and sub-nanomolar potency, Coibamide A (CA), an N-methyl-stabilized depsipeptide isolated from marine cyanobacterium, has been considered as a promising lead compound for cancer treatment. However, the molecular anti-cancer mechanism of the action of CA remains unclear. Here, we showed that CA treatment induced caspase-independent cell death in breast cancer cells. CA treatment also led to severe lysosome defects, which was ascribed to the impaired glycosylation of lysosome membrane protein LAMP1 and LAMP2. As a consequence, the autophagosome-lysosome fusion was blocked upon CA treatment. In addition, we presented evidence that this autophagy defect partially contributed to the CA treatment-induced tumor cell death. Together, our work uncovers a novel mechanism underlying the anti-cancer action of CA, which will promote its further application for cancer therapy.

摘要

天然产物是研究生物机制和发现药物的有用工具。由于具有优异的肿瘤细胞生长抑制作用和亚纳摩尔效力,从海洋蓝藻中分离得到的 N-甲基稳定的脱肽 Coibamide A(CA)被认为是一种有前途的癌症治疗先导化合物。然而,CA 的分子抗癌作用机制尚不清楚。在这里,我们表明 CA 处理诱导乳腺癌细胞中的 caspase 非依赖性细胞死亡。CA 处理还导致严重的溶酶体缺陷,这归因于溶酶体膜蛋白 LAMP1 和 LAMP2 的糖基化受损。结果,自噬体-溶酶体融合在 CA 处理时受阻。此外,我们提供的证据表明,这种自噬缺陷部分导致了 CA 处理诱导的肿瘤细胞死亡。总之,我们的工作揭示了 CA 抗癌作用的新机制,这将促进其在癌症治疗中的进一步应用。

相似文献

1
Coibamide A kills cancer cells through inhibiting autophagy.科伊酰胺 A 通过抑制自噬杀死癌细胞。
Biochem Biophys Res Commun. 2021 Apr 2;547:52-58. doi: 10.1016/j.bbrc.2021.01.112. Epub 2021 Feb 13.
2
Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts.柯巴酰胺A,一种天然的套索缩肽,可抑制VEGFA/VEGFR2表达并抑制胶质母细胞瘤异种移植瘤的生长。
Invest New Drugs. 2016 Feb;34(1):24-40. doi: 10.1007/s10637-015-0303-x. Epub 2015 Nov 12.
3
Coibamide A induces mTOR-independent autophagy and cell death in human glioblastoma cells.考巴酰胺 A 诱导人胶质母细胞瘤细胞中的 mTOR 非依赖性自噬和细胞死亡。
PLoS One. 2013 Jun 6;8(6):e65250. doi: 10.1371/journal.pone.0065250. Print 2013.
4
Identification of compound CA-5f as a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer.鉴定化合物 CA-5f 为一种新型晚期自噬抑制剂,对非小细胞肺癌具有显著的抗肿瘤作用。
Autophagy. 2019 Mar;15(3):391-406. doi: 10.1080/15548627.2018.1511503. Epub 2018 Sep 6.
5
ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.脂联素/脂联素通过 STK11/LKB1 介导的 AMPK-ULK1 轴激活诱导乳腺癌细胞细胞毒性自噬。
Autophagy. 2017 Aug 3;13(8):1386-1403. doi: 10.1080/15548627.2017.1332565. Epub 2017 Jul 11.
6
Autophagic flux disruption contributes to Ganoderma lucidum polysaccharide-induced apoptosis in human colorectal cancer cells via MAPK/ERK activation.自噬通量的破坏通过 MAPK/ERK 激活促进灵芝多糖诱导的人结直肠癌细胞凋亡。
Cell Death Dis. 2019 Jun 11;10(6):456. doi: 10.1038/s41419-019-1653-7.
7
Cadmium-induced cytotoxicity in mouse liver cells is associated with the disruption of autophagic flux via inhibiting the fusion of autophagosomes and lysosomes.镉诱导的小鼠肝细胞毒性与自噬小体与溶酶体融合的抑制导致自噬流的破坏有关。
Toxicol Lett. 2020 Mar 15;321:32-43. doi: 10.1016/j.toxlet.2019.12.019. Epub 2019 Dec 17.
8
Cadmium disrupts autophagic flux by inhibiting cytosolic Ca-dependent autophagosome-lysosome fusion in primary rat proximal tubular cells.镉通过抑制原代大鼠近端肾小管细胞中胞质钙依赖性自噬体-溶酶体融合来破坏自噬流。
Toxicology. 2017 May 15;383:13-23. doi: 10.1016/j.tox.2017.03.016. Epub 2017 Mar 25.
9
Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network.长春新碱介导线粒体 MYO1C 的下调通过阻断 F-肌动蛋白网络抑制自噬体-溶酶体融合。
J Exp Clin Cancer Res. 2019 Nov 7;38(1):457. doi: 10.1186/s13046-019-1449-8.
10
A novel autophagy inhibitor berbamine blocks SNARE-mediated autophagosome-lysosome fusion through upregulation of BNIP3.一种新型自噬抑制剂小檗胺通过上调 BNIP3 阻断 SNARE 介导的自噬体-溶酶体融合。
Cell Death Dis. 2018 Feb 14;9(2):243. doi: 10.1038/s41419-018-0276-8.

引用本文的文献

1
Phycocompounds from Cyanobacteria: Exploring Synergistic Effects with Conventional Anticancer and Antimicrobial Properties.蓝藻中的藻类化合物:探索与传统抗癌和抗菌特性的协同效应。
ACS Omega. 2025 Jun 5;10(23):23957-23980. doi: 10.1021/acsomega.5c03526. eCollection 2025 Jun 17.
2
Exploring the ER channel protein Sec61: recent advances in pathophysiological significance and novel pharmacological inhibitors.探索内质网通道蛋白Sec61:病理生理意义及新型药理学抑制剂的最新进展
Front Pharmacol. 2025 Jun 4;16:1580086. doi: 10.3389/fphar.2025.1580086. eCollection 2025.
3
Progress in the discovery and development of anticancer agents from marine cyanobacteria.
从海洋蓝细菌中发现和开发抗癌药物的进展。
Nat Prod Rep. 2025 Feb 19;42(2):208-256. doi: 10.1039/d4np00019f.
4
Deficiency Induced Granulosa Cell Senescence Through STAT1/ATF4 Mediated UPR and STAT1/(ATF4)/HIF1α/BNIP3 Mediated Mitophagy: Prevented by Enocyanin.通过 STAT1/ATF4 介导的 UPR 和 STAT1/(ATF4)/HIF1α/BNIP3 介导的线粒体自噬导致的颗粒细胞衰老:恩诺沙星可预防。
Int J Mol Sci. 2024 Oct 16;25(20):11122. doi: 10.3390/ijms252011122.
5
Diastereomers of Coibamide A Show Altered Sec61 Client Selectivity and Ligand-Dependent Activity against Patient-Derived Glioma Stem-like Cells.柯巴酰胺A的非对映异构体对患者来源的胶质瘤干细胞样细胞表现出改变的Sec61底物选择性和配体依赖性活性。
ACS Pharmacol Transl Sci. 2024 May 14;7(6):1823-1838. doi: 10.1021/acsptsci.4c00049. eCollection 2024 Jun 14.
6
Design of Synthetic Surrogates for the Macrolactone Linker Motif in Coibamide A.柯巴酰胺A中大环内酯连接基序的合成替代物设计
ACS Med Chem Lett. 2023 Sep 19;14(10):1344-1350. doi: 10.1021/acsmedchemlett.3c00232. eCollection 2023 Oct 12.
7
Depsipeptides Targeting Tumor Cells: Milestones from In Vitro to Clinical Trials.针对肿瘤细胞的去端肽酶:从体外到临床试验的里程碑。
Molecules. 2023 Jan 9;28(2):670. doi: 10.3390/molecules28020670.
8
Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies.海洋启发药物和生物材料在胰腺癌治疗中的应用
Mar Drugs. 2022 Nov 1;20(11):689. doi: 10.3390/md20110689.
9
Marine Cyanobacteria as Sources of Lead Anticancer Compounds: A Review of Families of Metabolites with Cytotoxic, Antiproliferative, and Antineoplastic Effects.海洋蓝细菌作为抗癌铅化合物的来源:具有细胞毒性、抗增殖和抗肿瘤作用的代谢产物家族综述。
Molecules. 2022 Jul 27;27(15):4814. doi: 10.3390/molecules27154814.
10
Antitumor Potential of Immunomodulatory Natural Products.免疫调节天然产物的抗肿瘤潜力。
Mar Drugs. 2022 Jun 8;20(6):386. doi: 10.3390/md20060386.